ArticleCancer cell international2020

Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines.

L-M Sklarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.